Lawrence Young

51 - 60 out of 149Page size: 10

Publications

  1. Published

    The role of CD40 in the pathogenesis and treatment of cancer

    Aris Eliopoulos & Lawrence Young, 1 Jan 2004, In: Current Opinion in Pharmacology. 4, p. 360-367 8 p.

    Research output: Contribution to journal › Review article

  2. Published

    CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus

    Peter Searle, Lawrence Young & Daniel Palmer, 1 Mar 2010, In: Molecular Cancer. 9, p. 52 1 p.

    Research output: Contribution to journal › Article

  3. Published

    CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals.

    Lawrence Young & Daniel Palmer, 15 Jan 2010, In: Journal of Immunology. 184, 2, p. 1111-20 10 p.

    Research output: Contribution to journal › Article

  4. Published

    Epstein-Barr virus induces cellular transcription factors to stimulate expression of EBER genes by RNA polymerase III

    Christopher Dawson, John Arrand, Lawrence Young, 7 Aug 2006, In: Journal of Biological Chemistry. 281, p. 33871-33880 10 p.

    Research output: Contribution to journal › Article

  5. Published

    The effect of Epstein-Barr virus status on survival in age and sex defined subgroups of patients with advanced Hodgkin's disease

    Lucinda Billingham, Joanne Gough, Lawrence Young & Paul Murray, 1 Feb 2003, In: Annals of Oncology. 14, 2, p. 282-290 9 p.

    Research output: Contribution to journal › Article

  6. Published

    South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

    Judy Powell, Lawrence Young & Paul Murray, 3 Aug 2001, In: British Journal of Cancer. 85, p. 350-356 7 p.

    Research output: Contribution to journal › Article

  7. Published

    CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis and cytokine secretion

    Neil Gallagher, Aris Eliopoulos, Angelo Agathanggelou & Lawrence Young, 1 Apr 2002, In: Molecular Pathology. 55, 2, p. 110-120 11 p.

    Research output: Contribution to journal › Article

  8. Published

    Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells

    Joanne Gough, Karl Baumforth, Wenbin Wei, Gemma Kelly, Lawrence Young & Paul Murray, 1 Jan 2008, In: Blood. 111, 1, p. 292-301 10 p.

    Research output: Contribution to journal › Article

  9. Published

    Nitroimidazole reductase and virally directed enzyme prodrug therapy

    Nicky Green, Vivien Mautner, Lawrence Young, Peter Searle & David Kerr, 1 Jan 2001, In: Cancer Gene Therapy. 8, p. 25-27 3 p.

    Research output: Contribution to journal › Article

  10. Published

    Immune enhancement of nitroreductase-induced cytotoxicity: Studies using a bicistronic adenovirus vector

    Nicky Green, Peter Searle, David Kerr & Lawrence Young, 10 Mar 2003, In: International Journal of Cancer. 104, 1, p. 104-112 9 p.

    Research output: Contribution to journal › Article

Previous 12 3 4 5 6 7 8 9 ...15 Next